Skip to content

IMDX IMDX Other income, net (Note 6)

Other income, net (Note 6) at other companies

CareDx logo
CareDxCDNA
-$330K-212%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
$10K-85.3%
Guardant Health logo
Guardant HealthGH
Natera, Inc. logo
Natera, Inc.NTRA
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
Agilent Technologies logo
Agilent TechnologiesA

Other financials

Income statement

See full
Revenue$32.0K-98.5%
Gross profit$15.0K-98.9%
Operating income-$4.4M+35.1%
Net income-$4.3M+35.7%
EPS (diluted)-$0.12+53.8%

Balance sheet

See full
Cash & equivalents$28.2M-9.1%
Total debt$2.9M-13.5%
Total equity-$10.7M-205%
Total assets$40.4M-33.0%

Cash flow

See full
Operating cash flow-$7.6M-30.8%
CapEx$613.0K+99.7%
Free cash flow-$8.3M-34.3%

Valuation

See full
Market cap$185.35M+92.3%
Enterprise value$160.03M+113%
P/S95.1×+72.5×

Profitability

See full
Gross margin51.3%-3.0pp
Operating margin-2,500.7%+4,459pp
Net margin-2,454.6%+4,017pp
FCF margin-1,409.7%-6,023pp

Returns & leverage

See full
Return on equity-532.9%-717pp
Debt / equity2.9×+2.8×
Current ratio2.5×-1.2×

Where this comes from

Reported directly by IMDX in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The official record: IMDX’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about IMDX's other income, net (note 6).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is IMDX's other income, net (note 6)?
IMDX (IMDX) reported other income, net (note 6) of $146K in Q1 2026.
How has IMDX's other income, net (note 6) changed year-over-year?
IMDX's other income, net (note 6) decreased by 7.0% year-over-year, from $157K to $146K.
What is the long-term trend for IMDX's other income, net (note 6)?
Over 4 years (2021 to 2025), IMDX's other income, net (note 6) has grown at a 128.6% compound annual growth rate (CAGR), from -$37K to $1.01M.
What does other income, net (note 6) mean?
This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.